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FOLLOWING the original observation of Cramer, Miller and Miller (1960) that
an N-hydroxylated metabolite of 2-acetamidofluorene (AAF) was formed in the
rat, N-hydroxylation of a number of carcinogenic aromatic amines in susceptible
species has been reported. Thus an N-hydroxylated metabolite of 4-acetamido-
biphenyl was demonstrated in the rat (Miller, Wyatt, Miller and Hartmann, 1961)
whilst similar metabolic conversions of 2-naphthylamine have been observed in
both rat (Boyland, Manson and Nery, 1960) and man (Troll and Nelson, 1961).
N-Hydroxylation of carcinogenic aromatic amines in vitro by tissue homo-
genates or sub-cellular fractions has also been reported. Hence IJehleke (1963)
detected N-oxidation of several carcinogenic arylamines by rat liver microsomes
andNADPH2byestimation oftheresultinghydroxyamino andnitroso compounds.
The formation of N-hydroxy-AAF following incubation of AAF with rabbit
liver microsomes has been demonstrated more directly by identification of the
metabolite (Irving, 1964; Booth and Boyland, 1964) whilst Booth and Boyland
(1964) also showed N-hydroxylation of 4-acetamidobiphenyl and N-acetylbenzi-
dine.
Investigations of the carcinogenicity of these compounds have shown that, in
general, the N-hydroxy derivatives are more active than the parent amides.
Thus N-hydroxy-2-acetamidofluorene was shown (Miller, Miller and Hartmann,
1961) to be more active than AAF towards rat liver and additionally, induced
tumours at other sites including the peritoneum and forestomach. Similarly,
N-hydroxy-4-acetamidobiphenyl proved to have an enhanced carcinogenic
activity with a greater spectrum of action (Miller, Wyatt, Miller and Hartmann,
1961) and 2-naphthylhydroxylamine was a more potent carcinogen than the
parent amide (Boyland, Dukes and Grover, 1963).
trans-4-Aminostilbene and its derivatives, initally studied on account of their
tumour inhibitory properties (Haddow, Harris, Kon and Roe, 1948), are highly
carcinogenic inthe ratinducing ear duct carcinomata following oraladministration.
These compounds thus provide a further class ofaromatic amines for investigation
of the significance of N-hydroxylation in carcinogepesis. The present paper
describes the metabolic transformations of aminostilbene compounds in the rat
particularly with reference to the formation of N-hydroxy-derivatives, and their
further metabolic reactions.
EXPERIMENTAL
Synthesis ofcompounds
In these studies, only the trans isomers of 4-aminostilbene and its derivatives
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were examined. These compounds were prepared by the following methods.
N-Hydroxy-4-acetamidostilbene (N-hydroxy-AAS)-was prepared by reduction
of4-nitrostilbene using a modification ofthe procedure developed for the synthesis
of 4-hydroxyaminobiphenyl (Bell, Kenyon and Robinson, 1926).
A solution of 4-nitrostilbene (1 g.) in ether (100 ml.), (previously distilled from
sodium hydroxide and saturated with water) was cooled in ice. Aluminium
amalgam, freshly prepared by treating aluminium foil (0-5 g.) with 2 per cent
mercuric chloride solution was added gradually and the mixture which was kept
at 00 C., was stirred at intervals over a period of 2 hours. The mixture was then
filtered, and the filtrate treated with acetic anhydride (2 ml.) for 1 hour at 40 C.
The precipitate which formed was collected, dissolved in ether: ethanol: acetone
mixture (3: 1: 1 by volume) and extracted with 0 5 N sodium hydroxide. The
alkali extract was neutralized with conc. hydrochloric acid and re-extracted with
the ether : ethanol: acetone mixture. This extract was washed withwater, dried
over anhydrous sodium sulphate and taken to dryness under reduced pressure
(yield 70 per cent). Recrystallization of the residue from benzene at least four
times yielded the acetylated hydroxylamine as white needles (yield 30 per cent}
M.P. (uncorr.) 2000 C. (Found, C, 76-1; H, 5-9; N, 5*3; C16H15NO2 requires,
C, 75-9; H, 6'0; N, 55).
Absorption maximum (in ethanol) 325 m/t; E, 3.77 x 104
Fluorescence Characteristics: Excitation maximum, 332 mut.
Fluorescence maximum, 395 mi,n.
The synthesis of N-hydroxy-arylamines by this method is now being investi-
gated in greater detail (Partridge and Knowles, personal communication).
Andersen, Enomoto, Miller and Miller (1964) have reported the synthesis of N-
hydroxy-AAS bycatalytic reductive acetylation of4-nitrostilbene with apalladium
catalyst (yield: 10 per cent).
4-Acetamidostilbene (AAS) was prepared by reduction of 4-nitrostilbene with
hydrazine and Raney Ni and acetylation of the resulting amine M.P. 2340 C.
4-Dimethylaminostilbene (DAS) wasprepared bythe actionofbenzylmagnesium
chloride on p-dimethylaminobenzaldehyde (Sachs and Sachs, 1905) M.P .1480 C.
4'-Hydroxy-4-acetamidostilbene (4'-hydroxy-AAS) wasprepared bycondensation
of p-acetamido phenylacetic acid and p-hydroxybenzaldehyde (Masserani, 1957)
MP. 2380 C.
4'-Hydroxy-4-aminostilbene (4'-hydroxy-AS) was prepared by condensation of
p-aminophenylacetic acid and p-hydroxybenzaldehyde (Masserani, 1957) M.P.
2730 C.
Metabolism studies
Male Wistar rats, initially 180 g. to 220 g. in weight, were used for metabolism
studies. These were housed in groups of four in metabolism cages and provided
with water ad libitum. Aminostilbene compounds were fed in a low proteindiet
(Elson, 1952) which contained cornstarch (850 g.), crude casein (50 g.), Bemax
(25 g.), margarine (50 g.), calcium carbonate (5 g.), Glaxo salt mixture (10 g.).
cod liver oil (10 g.), and methionine (4 g.). The compounds were incorporated
into the diet at a level of 40 mg./kg. as a suspension in melted margarine. Food
consumption studies indicated that the daily intake under these conditions was
approximately 0 5 mg./rat. These powdered diets were administered continuously
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during metabolism studies, utilizing non-spill food containers. Urine samples
were collected daily under toluene, clarified by centrifugation and, unless used
immediately, stored at -20° C.
For enzymatic hydrolysis of conjugated metabolites, urine samples (5 ml.)
were diluted with water (20 ml.) and sodium acetate buffer, 1 M pH6 (4 ml.)
added. /8-Glucuronidase (5 mg.) and Taka diastase (5 mg.) were added together
with a few drops of chloroform and the mixture incubated at 370 C. for 18 hours.
Metabolites werethenextractedinto ether: ethanol (3: 1 v/v) mixture. Hydroxy-
lated derivatives were further separated by extraction into sodium hydroxide,
0*5 N. These extracts were then neutralized with conc. hydrochloric acid and the
metabolites re-extracted into ether : ethanol: acetone mixture (3: 1: 1).
Metabolism ofAminostilbene compounds in vitro
In vitro metabolism studies were carried out with whole liver homogenates
and also sub-cellular fractions prepared from 3-4 month old Wistar male rats fed
on a standard cubed diet (M.R.C. diet 41). Rats were killed by cervical dislocation
and livers perfused with ice cold 015M sodium chloride and 0-25M sucrose.
Liver homogenates (20 per cent v/v) were then prepared in 0-25 M sucrose and
fractions isolated by differential centrifugation. Mitochondria were sedimented
-at 10,000 g for 10 minutes and the pellets washed once by resuspension in one
volume of 025M sucrose. Following re-sedimentation (10,000 g, 15 minutes),
these fractions were finally suspended in one volume of 0-25 M sucrose. Micro-
some fractions were isolated from mitochondrial supernatants by centrifugation
at 105,000 g for 60 minutes. The supernatant (cell sap) fraction was removed and
the microsome pellet re-suspended in 0-25 M sucrose. The cell sap and microsome
fractions were then re-centrifuged (105,000 g, 60 minutes) and the microsome
pellet finally re-suspended in 0-25M sucrose (1 volume).
For assay, 200 mg. wet weight of liver or fractions from an equivalent weight
of tissue were incubated aerobically in a medium containing 15 ,Umole glucose-6-
phosphate (sodium salt); 0 3 ,tmole NADP (sodium salt), 300 ,tmoles nicotin-
amide, 150 /,moles potassium chloride and 150 ,umoles sodium phosphate buffer
(pH 7.4) in a total volume of 449 ml. Aminostilbene compounds (50 ,tg.) were
added in ethanol (0 1 ml.) and incubated in air at 370 C. for 2 hours with constant
gentle agitation. Metabolism was stopped by immersing flasks in boiling water
for 5 minutes and metabolites were extracted into ether: ethanol (3: 1 v/v
mixture.
Detection and e8timation ofaminostilbene metabolites
Extracts containing aminostilbene metabolites were examined utilizing the
following procedures.
Paper chromatography on Whatman No. 1 paper by the ascending technique
using tert-butanol: formic acid: water (70: 15: 15 by volume) as developing
solvent.
Paper electrophoresis on Whatman No. 1 paper using 30 per cent acetic acid
as electrolyte. Electrophoresis was carried out for 12-18 hours with a potential
gradient of 20 v/cm. (Current 3 ma./10 cm. wide-paper strip).
Thin layer chromatography.-Thin layer chromatography was carried out on
20 cm. x 20 cm. or 20 cm. x 10 cm. glass plates coated with a layer 0-2 mm. thick
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of silica gel G (Merck). Two developing systems were generally used; benzene:
ethanol (9: 1 v/v) and benzene: acetone (3: 1 v/v) and these allowed separation
of all the reference compounds (Table I).
TABLE I.-Chromatography of 4-Amino8tilbene Compounds
Paper chromatography Thin layer silica gel
Whatman No. 1. chromatography.
Developing solvent- Developing solvent
butanol: formic acid: , A
water (70: 15: 15) Benzene: ethanol Benzene: acetone
Compound by volume (9: 1 v/v) (3: 1 v/v)
Rf Rf Rf
4-acetamidostilbene (AAS) . 086 . 0-21 0-48
N-hydroxy-AAS . 0 83 0 20 0 30
4'-hydroxy-AAS 0 78 . 0 08 0 28
3-hydroxy-AAS. . . . 0 26 0-57
4-aminostilbene (AS) . 0 88-0 90 . 0 70 0 76
4'-hydroxy-AS . . . 0 75-0 79 . 019 0-49
Metabolites were visualized by direct observation of their blue fluorescence
under ultraviolet light or by spraying with one of the following reagents:
(a) p-dimethylaminobenzaldehyde (1 %) in N HCI (Cramer, Miller and Miller,
1960).
(b) Diazotization with nitrous acid followed by coupling with , naphthol (5%)
in 2N NaOH.
(c) Ferric chloride (0.3%)-Potassium ferricyanide (0.3 %) (Smith, 1960).
Quantitative estimation ofN-hydroxy-AAS
Determination ofthe concentration ofN-hydroxy-AAS was carried oututilizing
the colorimetric procedure of Sawicki, Stanley, Hauser, Elbert and Noe (1961)
for detecting aromatic amines and imino heteroaromatic compounds.
Zones from paper chromatograms containing N-hydroxy-AAS were eluted
with hot acetone and the extracts evaporated to dryness. The residues were
redissolved in methanol (1 ml.) and aqueous 0-2 per cent 3-methyl-2-benzothiazo-
lone hydrazone (1 ml.) BDH and 1-3 per cent ferric chloride (2 ml.) added. After
15 minutes, distilled water (2 ml.) was added and the mixture extracted with
chloroform (4 ml.). The chloroform layer was then removed and its extinction
measured at 675 m,u in a Unicam S.P. 600 spectrophotometer.
Silicic acid chromatography ofurinary metabolit&s
Partition chromatography of urinary metabolites on silicic acid (Mallinckrodt,
100 mesh) was carried out essentially as described by Weisburger, Weisburger,
Morris and Sober (1956). Samples were applied to the columns (2 x 38 cm.) in
tert-butanol and elution carried out with the organic phase from a mixture of
cyclohexane : tert-butanol : glacial acetic acid : water (16 : 4: 2: 1; by vol.). The
eluate was collected in 5 ml. samples and examined for aminostilbene compounds
by determination of the extinction at 320 m,z in a S.P. 600 spectrophotometer.
RESULTS
Urinary metabolism
Paper chromatography of ether: ethanol (1: 1) extracts of enzymatically
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hydrolysed urine from rats fed 4-acetamidostilbene (AAS) allowed detection, by
comparison with reference compounds, of4'-hydroxy-AAS (Rf 0.78) and 4-amino-
stilbene (Rf 0 88-0 90). Both metabolites exhibited blue fluorescence under
-ultraviolet light whilst the zone corresponding to 4'-hydroxy-AAS reacted with the
-ferric chloride-ferricyanide reagent to give a deep blue colour. Furthermore,
the zone identified as 4-aminostilbene, like the authentic compound, reacted with
nitrous acid and alkaline /8-naphthol to produce a red dye.
Following extraction of the ether-ethanol extracts with dilute alkali, paper
chromatography ofthe acidic metabolites enabled a third metabolite to be detected
-with an Rf (0.83) identical to that of authentic N-hydroxy-4-acetamidostilbene
(N-hydroxy AAS). This zone and the authentic N-hydroxy-AAS reacted slowly
with acidic f,-dimethylaminobenzaldehyde and with the ferric chloride-potassium
ferricyanide reagent. The metabolite also migrated at the same rate as the
-authentic N-hydroxy AAS (migration distance 11 cm.) following paper electro-
phoresis in 30 per cent acetic acid for 12 hours (potential gradient 20 v/cm.) and
was well separated from the 4'-hydroxy-AAS derivative (migration distance
9.5 cm.).
Further characterization ofthe hydroxylated metabolites was obtained follow-
ing silicic acid column chromatography. Bulk urine samples (1 L.) obtained
from a group of 40 rats fed continuously on the low protein diet containing AAS
were treated with f8-glucuronidase and Taka diastase and metabolites extracted
into ether: ethanol (3: 1 v/v). The hydroxylated metabolites isolated by
extraction with 05 N NaOH were then fractionated by partition chromatography
on a silicic acid column using cyclohexane : tert-butanol: acetic acid: water
(16: 4: 2: 1 by volume) as eluting solvent (Weisburger, Weisburger, Morris and
Sober, 1956). Two main acidic components were separated (Fig. 1) and thefirst
fraction (A) eluted under conditions almost identical to those necessary for the
separation of N-hydroxy-AAS. The second fraction (B) was less homogeneous,
butcomparisonwiththeelutionprofiles ofknowncompoundsindicatedthepresence
of 4'-hydroxy-AAS.
The identity ofthese two metabolites as N-hydroxy-AAS and 4'-hydroxy-AAS
was further demonstrated by comparison of their paper chromatographic proper-
ties with the authentic compounds. Furthermore the ultraviolet absorption
spectra of these metabolites (A and B) in the eluting solvent (cyclohexane : tert-
butanol: acetic acid : water, 10 : 4: 2: 1) were identical with those ofN-hydroxy-
AAS (Amax 280 m,t) and 4'-hydroxy-AAS (Amax 302 m,u) respectively.
Quantitative studies indicated that initially, N-hydroxy-AAS was excreted in
urine at a level of 9 ,ug./rat/24 hours (approximately 2 per cent ofthe administered
dose). This is somewhat higher than the level (0.38-0.47 per cent) reported by
Andersen, Enomoto, Miller and Miller (1964) following intraperitoneal administra-
tion of AAS. The level of N-hydroxy-AAS excreted decreased to approximately
4 ,ug./rat/24 hours after 4 weeks of AAS feeding, but then increased again so
that after 12 weeks, the level was approximately equivalent to that initially
observed.
In similar studies, it was demonstrated that N-hydroxy-AAS and 4'-hydroxy-
AAS were excreted in urine following oral administration of 4-dimethylamino-
stilbene. With this compound, thelevel ofN-hydroxy-AASexcreted wasinitially
low (1.5 ,ug./rat/24 hours); (0-3 per cent of dose) but increased with continuous
feeding to a level of 5 ,ug./rat/24 hours; 1 per cent of dose after 12 weeks.
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FIG. 1. Partition chromatography ofurinary metabolites ofAAS on silicic acid.
Fraction A-Pool of fractions from tubes 7-20
Fraction B-Pool of fractions from tubes 30-45.
Urinary metabolites.
- - - - - - - - - - Reference compounds.
Classification of urinary metabolites
Metabolites excreted in urine from rats fed AAS were fractionated into free
compounds and sulphuric acid and glucosiduronic acid conjugates by alumina
chromatography ofether: ethanol (3: 1 v/v) extracts ofurine using the procedure
of Weisburger, Grantham, Morris and Weisburger (1961). The conjugates with
sulphuric acid and glucosiduronic acid were then hydrolysed with Taka diastase
and f6-glucuronidase respectively and the liberated metabolites characterized by
paper and thin layer chromatography. These studies showed that most of the
N-hydroxy-AAS was present as a conjugate of glucosiduronic acid, whilst a small
amount was excreted as a sulphuric acid ester (Table II). The other major
metabolite detected, 4'-hydroxy-AAS, was present in the free form as well as
conjugated with glucosiduronic acid and sulphuric acid. In addition, a small
amount of 4-aminostilbene was detected as its glucosiduronic acid conjugate.
Metabolism ofN-hydroxy-AAS
Following oral administration of N-hydroxy-AAS to rats in the low protein
diet, only a small amount ofunchanged compound was excreted in urine (10 ,ug./24
hours; approx. 2 per cent of administered dose) and this was present mainly as a
glucosiduronic acid conjugate (Table II). The only other major metabolite
detected was 4'-hydroxy-AAS and this was present both in the free form and
conjugated to glucosiduronic acid. Additionally, a small amount of 4-amino-
stilbene was detected as its glucosiduronic acid conjugate (Table II).
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TABLE II.-Urinary Metabolites of4-Acetamidostilbene (AAS) andN-Hydroxy-AAS
Following Oral Administration to Rats
Metabolites detected as:-
Conjugates of
r
A
-
Compound Glucosiduronic
administered Free compounds acid Sulphuric acid
AAS . . 4'-hydroxy-AAS 4'-hydroxy-AAS 4'-hydroxy-AAS
N-hydroxy-AAS N-hydroxy-AAS
4-aminostilbene
(trace)
N-hydroxy-AAS 4'-hydroxy-AAS . N-hydroxy-AAS
N-hydroxy-AAS . 4'-hydroxy-AAS
4-aminostilbene
(trace)
Metabolism studies in vitro
Following incubation of AAS in vitro with rat liver homogenate in a system
which permitted hydroxylation, in addition to unchanged compound, two blue
fluorescent metabolites were detected by paper chromatography ofether: ethanol
(3: 1 v/v) extracts. These were identified by their staining reactions and by
reference to known compounds as N-hydroxy-AAS (Rf 0 83) and 4'-hydroxy-AAS
(Rf 0.78). The identities of these metabolites were further confirmed by com-
parison oftheir electrophoretic mobilities with those ofthe authentic compounds.
Additionally, they were also characterized by thin layer chromatography (Table I).
This technique also enabled the detection of two other metabolites which were
identified by comparison of their Rfs and staining reactions with known com-
pounds as 4-aminostilbene and 4'-hydroxy-4-aminostilbene (Table III).
When N-hydroxy-AAS was incubated in vitro with rat liver homogenate, the
only metabolite detected was 4'-hydroxy-AAS together with unchanged compound
(Table III).
TABLE III.-Metabolism of 4-Aminostilbene Compounds
by Rat Liver Homogenate*
Substrate Metabolites identified
4-acetamidostilbene (AAS) N-hydroxy-AAS
4'-hydroxy-AAS
4'-aminostilbene
4'-hydroxy-4-aminostilbene
N-hydroxy-AAS . 4'-hydroxy-AAS
* Reaction mixtures and incubation conditions are described in the Methods section. The
metabolites were identified on paper or thin layer chromatograms by comparison of their Rfs and
colour reactions.
Intracellular localization ofN-hydroxylating enzymes
Comparison of the metabolic activity of subcellular fractions of rat liver
demonstrated that the N-hydroxylating enzymes were located mainly in the
microsome fraction, although co-factors in the cell sap were required (Table IV).
Additionally, a small amount of N-hydroxy-AAS was detectable when AAS was
incubated with the combined mitochondria-cell sap fractions.
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TABLE IV.-Metabolism of 4-acetamidostilbene (AAS) by
Sub-cellular Fractions of Rat Liver
Cell fraction* Metabolites detected
Microsomes . . None
Cell sap . None
Microsomes + cell sap . N-hydroxy-AAS
4 -hydroxy-AAS
Mitochondria . None
Mitochondria + cell sap. N-hydroxy-AAS
* Each cell fraction (equivalent to 200 mg. wet weight of liver) was suspended in the standard
incubation system described in the Methods.
DISCUSSION
The present studies indicate that an N-hydroxylated metabolite is formed
following oral administration of 4-acetamidostilbene (AAS) in a low protein diet
to adult Wistar rats, and excreted in urine as conjugates of glucosiduronic acid
and sulphuric acid. This metabolite was also demonstrated in the urine of
rats treated similarly with 4-dimethylaminostilbene although the levels in urine
were lower than those detected in AAS-treated rats, presumably because of the
additional requirement of N-demethylation of this compound. Andersen,
Enomoto, Miller and Miller (1964) have also reported that AAS is metabolized
to N-hydroxy-AAS following intraperitoneal administration to weanling rats.
Furthermore, they were able to isolate sufficient ofthis metabolite from rats which
received intraperitoneal injections of the less toxic 4-aminostilbene to permit its
unequivocal identification by elementary analysis and by comparison ofits physical
properties with those of the authentic compound.
The other major metabolite detected in urine following oral administration
of AAS or the N-hydroxy derivative was 4'-hydroxy-AAS, which was present in
the free form and also as conjugates with glucosiduronic acid and sulphuric acid.
Additionally, a small amount of4-aminostilbene was detected as its glucosiduronic
acid conjugate. These findings differ from those of Andersen, Enomoto, Miller
and Miller (1964) where the major metabolite detected in urine following intra-
peritoneal injection of AAS or N-hydroxy-AAS was the o-hydroxy derivative,
3-hydroxy-AAS, although two unknown metabolites were detected one of which
was identified tentatively as 4'-hydroxy-AAS. There were, however, a number
of variations between the experimental systems used in the present studies and
thoseofAndersen, Enomoto, Miller and Miller (1964),including differencesbetween
the strains of rats, the route of administration of compounds and probably most
significantly, the nutritional status ofthe animals. Hence Weisburger, Grantham
and Weisburger (1964) have recently reported differences in the metabolism of
N-hydroxy-2-acetamidofluorene (N-hydroxy-AAF) in male and female rats,
particularly with regard to the formation of ring hydroxylated derivatives.
It has also been reported (Margreth, Lotlikar, Miller and Miller, 1964) that the
levels of the urinary metabolites of AAF excreted by rats depended upon the
dietary protein content. Thus the levels of one metabolite, 7-hydroxy-AAF, were
15 per cent and 24 per cent of the administered dose in rats maintained on diets
containing casein at 50 per cent and 18 per cent respectively.
AAS was also converted to the N-hydroxy derivative by rat liver homogenate
in a system which supports hydroxylation and the enzymes involved were shown
to be contained in the microsome fraction. The other metabolites formed
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following incubation of AAS with rat liver homogenate were 4'-hydroxy-AAS,
4'-hydroxy-4-aminostilbene and 4-aminostilbene. The only metabolite detected
following incubation of N-hydroxy-AAS in the rat liver homogenate system was
4'-hydroxy-AAS.
These findings are in agreement with recent studies demonstrating N-hydroxy-
lation of carcinogenic aromatic amines by rat and rabbit liver homogenates or
suitably fortified microsome fractions. Thus Irving (1962, 1964) and Booth and
Boyland (1964) have detected N-hydroxy-AAF following incubation of AAF with
rabbit liver microsomes in the presence of NADPH2 and oxygen. Booth and
Boyland (1964) also showed that 4-acetamidobiphenyl and N-acetylbenzidine
were converted to the N-hydroxy metabolites by rabbit liver microsomes, whilst
further metabolism of 4-acetamidobiphenyl resulted in hydroxylation at both the
4'- and 3- positions. The 4'-hydroxy metabolites were considered to arise by
direct hydroxylation of 4-acetamidobiphenyl or the deacetylated derivative
whereas o-hydroxylation was thought to arise from further metabolism of the
N-hydroxylated metabolites.
Whilst there are some differences between the present studies and those of
Andersen, Enomoto, Miller and Miller (1964) regarding the nature of the ring
hydroxylated metabolites of AAS, it is doubtful whether these derivatives are
directly involved in the carcinogenic process. Hence it has been demonstrated
(Baldwin, Smith and Surtees, 1963a) that 4'-hydroxy-AAS is not carcinogenic
when administeredorallyto ratsunderconditionswherebyAAS andtheN-hydroxy
derivative arehighlycarcinogenic (Baldwin, SmithandSurtees, 1963b). Similarly,
in studies still incomplete, Andersen, Enomoto, Miller and Miller (1964) have
reported the inactivity of 3-hydroxy-AAS following subcutaneous injection into
rats. These findings, together with the observation of high carcinogenic activity
in N-hydroxy-AAS (Baldwin, Smith and Surtees, 1963b; Andersen, Enomoto,
Miller and Miller, 1964) suggest that N-hydroxylation is a critical metabolic
change, necessary for carcinogenicity in the aminostilbenes, whereas ring hydroxy-
lation represents a detoxication change.
Although evidence is accumulating that N-hydroxylation is involved in
aromatic amine carcinogenesis, little is yet known about the nature ofthe cellular
interactions with N-hydroxy metabolites. That arylhydroxylamines are highly
reactive substances has been demonstrated by Boyland, Manson and Nery (1962),
and Weisburger, Grantham and Weisburger (1964) have reported in vivo binding
of N-hydroxy-AAF to tissue protein. Furthermore, the possibility of direct
interactions with nucleic acids may be relevant since the mutagenic action of
hydroxylamine has been ascribed to its interaction with cytosine bases in DNA
(Freese, Bautz-Freese and Bautz, 1961) and Weisburger, Grantham and Weis-
burger (1964) have reported that the highly reactive deacetylated compound,
N-hydroxy-2-aminofluorene combines with nucleic acid as well as protein.
Arylhydroxylamines have also been shown to chelate with metal ions (Miller,
Enomoto and Miller, 1962; Weisburger, Grantham and Weisburger, 1963).
Hence thepossibility needs consideration ofin vivo interactions ofN-hydroxy-.AAS
with metal ions. Whilst the significance of such interactions remains to be eluci-
dated, there is evidence that metal ions can influence carcinogenesis (Howell, 1959
Miller, Enomoto and Miller, 1962; Fare and Howell, 1964).
In the studies of Baldwin, Smith and Surtees (1963b) all the tumours induced
following oral administration of AAS or the N-hydroxy-AAS arose in glands.
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associated with the external auditory meatus and no tumours developed in liver.
Investigations are now in progress to ascertain why the ear duct gland is sensitive
and the liver refractory to aminostilbene carcinogenesis, particularly since it has
been demonstrated that the liver is involved in N-hydroxylation ofthe carcinogen.
Body distribution studies have demonstrated that 24 hours following a single
intraperitoneal injection of 14C-labelled-AAS to rats, the level of radioactivity/g.
wet weight of tissue in the ear duct gland (5.4 x 104 counts/minute) was compar-
able to that in liver (4.7 x 104 counts/minute). Moreoverthe radioactive material
localized in the ear duct gland was found to persist (Baldwin and Romeril,
unpublished observations). Clearly, these observations may be highly relevant
in explaining tissue sensitivity to the carcinogenic action of aminostilbene
compounds. The nature ofthe radioactive metabolites and the processes involved
in their tissue distribution are now under investigation.
SUMMARY
1. N-hydroxy-4-acetamidostilbene (N-hydroxy-AAS) was identified as a
urinary metabolite following oral administration of 4-acetamidostilbene (AAS)
or 4-dimethylaminostilbene to rats. This metabolite was excreted mainly as a
conjugate with glucosiduronic acid together with a small amount as a sulphuric
acid ester.
2. The formation ofN-hydroxy-AAS was also demonstrated following incuba-
tion ofAAS with rat liver homogenate in a system which supported hydroxylation.
The enzymes involved in N-hydroxylation were contained in the microsomes
although co-factors in the cell sap fraction were necessary.
3. The other major urinary metabolite detected following oral administration
of AAS was 4'-hydroxy-4-acetamidostilbene (4'-hydroxy-AAS) and this was
excreted in the free form as well as conjugated with glucosiduronic acid and
sulphuric acids. 4'-hydroxy-AAS was also the major urinary metabolite identified
following oral administration ofN-hydroxy-AAS to rats.
4. 4'-Hydroxy-AAS was also formed following incubation of AAS or
N-hydroxy-AAS with the rat liver homogenate system. WithAAS, thedeacety-
lated metabolites 4-aminostilbene and 4'-hydroxy-4-aminostilbene were also
identified.
5. The results, together with the reported lack of carcinogenic activity of
ring hydroxylated aminostilbene compounds, supports the concept that
N-hydroxylation is a necessary stage for carcinogenic action.
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